- Cancer clinical trial eligibility criteria: available therapy in non-curative settings1
- Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic1
- Clinical decision support software: guidance for industry and Food and Drug Administration staff1
- Coast Guard health care: improvements needed for determining staffing needs and monitoring access to care : report to congressional committees1
- Comparability Protocols for postapproval changes to the chemistry, manufacturing, and controls information in an NDA, ANDA, or BLA: guidance for industry1
- Competitive generic therapies: guidance for industry1
- Compounding certain beta-lactam products in shortage under Section 503A of the Federal Food, Drug, and Cosmetic Act: immediately in effect guidance for industry1
- Computer-assisted detection devices applied to radiology images and radiology device data: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff1
- Connecticut Medicaid Fraud Control Unit: 2021 inspection1
- Contact tracing for air travel: CDC’s data system needs substantial improvement : report to congressional addressees1
- Cross labeling oncology drugs in combination regimens: guidance for industry1
- Defense health agency: oversight needed to better ensure that children are screened, tested, and treated for lead exposure : report to congressional committees1
- Defense health care: Actions needed to improve billing and collection of debt for civilian emergency care : report to congressional committees1
- Defense health care: DOD expects new IT system capabilities to improve other health insurance processing : report to congressional committees1
- Defense health care: Prevalence of and efforts to screen and treat mental health conditions in prenatal and postpartum TRICARE beneficiaries : report to congressional committees1
- Drug safety: FDA should take additional steps to improve its foreign inspection program : report to congressional requesters1
- During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections1
- E14 and S7B clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmic potential: questions and answers1
- E19: a selective approach to safety data collection in specific late-stage preapproval or post-approval clinical trials : guidance for industry1
- Electronic health information: HHS needs to improve communications for breach reporting : report to congressional committees1